Leaflet SIDARSO 4mg capsules


Indicated for: benign prostatic hyperplasia

Substance: silodosin (alpha-1 blocker)

ATC: G04CA04 (Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists)

Silodosin is a medication used for the treatment of symptoms of benign prostatic hyperplasia (BPH), such as difficulty urinating or frequent urination. It works by blocking alpha-adrenergic receptors in the prostate and bladder, relaxing the muscles and improving urinary flow.

The medication is taken orally, as directed by a doctor, usually once daily with food. It is important for patients to follow the prescribed dosage and inform the doctor of any unusual symptoms.

Patients should be aware of potential side effects, such as dizziness, fatigue, or low blood pressure. It is important to avoid activities requiring focus until they know how the medication affects them.

Common side effects include dizziness, fatigue, and low blood pressure. In rare cases, severe reactions such as priapism or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about SIDARSO 4mg

  • Substance: silodosin
  • Date of last drug list: 01-08-2019
  • Commercial code: W66131001
  • Concentration: 4mg
  • Pharmaceutical form: capsules
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 15199/2023/01
  • Shelf life: 2 years

Concentrations available for silodosin

  • 4mg
  • 8mg